about
Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantationAcetaminophen-induced Liver Injury: from Animal Models to HumansDiagnostic Performance of Des-γ-carboxy Prothrombin for Hepatocellular Carcinoma: A Meta-AnalysisBiomarkers: evaluation of screening for and early diagnosis of hepatocellular carcinoma in Japan and chinaSerum Alpha-Fetoprotein Predicts Treatment Outcome in Chronic Hepatitis C Patients Regardless of HCV GenotypeActivated p53 with Histone Deacetylase Inhibitor Enhances L-Fucose-Mediated Drug Delivery through Induction of Fucosyltransferase 8 Expression in Hepatocellular Carcinoma CellsFucosylation of N-glycans regulates the secretion of hepatic glycoproteins into bile ducts.New multi protein patterns differentiate liver fibrosis stages and hepatocellular carcinoma in chronic hepatitis C serum samples.Present and future possibilities for early diagnosis of hepatocellular carcinomaDecrease of Alpha-fetoprotein in Patients with Cirrhosis Treated with Direct-acting Antivirals.Alpha-1-acid glycoprotein as potential biomarker for alpha-fetoprotein-low hepatocellular carcinomaPrognosis evaluation in patients with hepatocellular carcinoma after hepatectomy: comparison of BCLC, TNM and Hangzhou criteria staging systems.Alpha-fetoprotein level as a biomarker of liver fibrosis status: a cross-sectional study of 619 consecutive patients with chronic hepatitis B.Purification and cDNA cloning of porcine brain GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1-->6fucosyltransferase.LC-MS based serum metabolomics for identification of hepatocellular carcinoma biomarkers in Egyptian cohort.Diagnostic performance of alpha-fetoprotein, lens culinaris agglutinin-reactive alpha-fetoprotein, des-gamma carboxyprothrombin, and glypican-3 for the detection of hepatocellular carcinoma: a systematic review and meta-analysis protocol.Molecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: one step closer to personalized medicine?Alpha-fetoprotein expression is a potential prognostic marker in hepatocellular carcinoma.Disruption of Dicer1 induces dysregulated fetal gene expression and promotes hepatocarcinogenesis.Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection.Differentiation of acute and chronic hepatitis B in IgM anti-HBc positive patients.Ultrasound guided fine needle biopsy of early hepatocellular carcinoma complicating liver cirrhosis: a multicentre study2D DIGE proteomic analysis highlights delayed postnatal repression of α-fetoprotein expression in homocystinuria model mice.Serum thioredoxin is a diagnostic marker for hepatocellular carcinoma.Hepatocyte paraffin 1: a monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors.Serum LncRNAs Profiles Serve as Novel Potential Biomarkers for the Diagnosis of HBV-Positive Hepatocellular Carcinoma.Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.Glypican-3 and alphafetoprotein as diagnostic tests for hepatocellular carcinoma.Expression of PEG10 Is Associated with Poor Survival and Tumor Recurrence in Hepatocellular Carcinoma.A novel core fucose-specific lectin from the mushroom Pholiota squarrosa.Serum Adiponectin, Vitamin D, and Alpha-Fetoprotein in Children with Chronic Hepatitis C: Can They Predict Treatment Response?Does HCV Patients Who Have BCL2 43Ala Genotype and Normal GH1 Levels Can Achieve Response to IFN Based Therapy?Relationship of α-fetoprotein levels and development of hepatocellular carcinoma in hepatitis C patients with liver cirrhosis.Antihepatoma effect of alpha-fetoprotein antisense phosphorothioate oligodeoxyribonucleotides in vitro and in miceThe Wnt pathway regulator DKK1 is preferentially expressed in hormone-resistant breast tumours and in some common cancer types.Glycocapture-assisted global quantitative proteomics (gagQP) reveals multiorgan responses in serum toxicoproteome.Future of molecular profiling of human hepatocellular carcinoma.Correlation and multiple regression analyses of pituitary growth hormone and hepatic activities in hepatitis C infection and interferon response.Clinicopathologic characteristics of intrahepatic cholangiocarcinoma in patients with positive serum a-fetoproteinA predictive model for carcinogenesis in patients with chronic hepatitis B undergoing entecavir therapy and its validation.
P2860
Q26772329-DC6D4D4E-2738-4F50-9F14-7AB4562D3572Q26781944-D218CFCC-01A3-4B66-A6D1-7B09DE3033A7Q26863560-0185FC2A-9CBC-4604-A18E-77098A64FF14Q27003291-F834FD64-3183-4F14-ADA5-F0FC38AD6C18Q27486169-21143EE1-C433-42DC-9A5B-E5E15A0D04B7Q28555059-626366EE-80A3-4158-AEA7-BF50AC7D2E96Q30821619-7602FD8D-644F-47B7-A26E-FB8CE0E0CB31Q33266698-7A29F704-4BB8-42B2-B29F-AF2C35444558Q33612167-16BFC60E-9106-4E4F-BA7D-2BCF3D2C05BBQ33621640-C9B4719B-3F07-465D-9F6D-CE8ED80BF7AAQ33752079-03482481-3C29-4CF6-AEB3-5B594CA82A96Q34061430-FB8AD609-DDD3-4AF1-8D26-DE43A4C5442FQ34071329-07FCF1B1-7C79-45C7-8C58-57EB5EBF8ED8Q34406765-F8769BAC-FA56-4359-91AB-23162B6D90C2Q34451211-A3761BEA-3042-48F9-92B4-5E07BE460A06Q34759365-826D6616-0486-4310-B773-CE8EC59FC2B2Q35048768-F5F282F3-87B2-4D5B-9300-7EE7610F92BFQ35064510-E4664AB7-857A-4096-97FB-CB890BD96E6EQ35197463-A9CE930E-32A4-46E4-B8B4-18C34ABEB1E3Q35269130-0C58F218-6B3C-4440-A534-A0184A786622Q35270350-DF77DA43-8C98-41FD-A660-E90E5EBA63CEQ35596794-C9782CA2-B876-4D6F-A456-B4F03B54F55DQ35704942-45084100-A4EC-4567-85E0-079C97AFC9ACQ35832440-DDBF4195-FBC4-40A8-A26A-C5162602ECC1Q35833243-659D46AD-DE69-4179-BA0B-E98BB1F33B66Q35870607-1CE29A60-676A-4D22-BA78-ADBAE3E017A3Q35987232-2FD596EF-C833-4D7C-93C7-CBB0427D3D10Q36124126-133E5C4E-EF87-43CF-8AFD-D6685D727523Q36186975-DE70D8BA-1588-482C-B958-ECA1D755CD7BQ36298291-411704B3-A9DE-48FD-B107-0AFE710299CAQ36310310-9450B81F-2ABA-403E-A9AD-577748B24936Q36336416-3E72C217-831F-455F-B993-631DA8187BE0Q36386685-6E057218-C181-4EB1-AFD5-7F65D74B6743Q36397382-9A71BF9E-09F5-4281-AC59-9A7E2D940889Q36609873-7D0F6CD3-E567-417B-B247-4304E5EAF418Q36642297-42C738AF-87C8-4783-AB11-B8D60EC21ECDQ36895812-70A0A2C5-03D8-4470-9D88-7C31322E652EQ37199380-ED950AFD-53AF-4DA2-8D97-5ACD38D23506Q37245513-C00E24F6-E202-4B8E-983B-2DF5A35D9C7EQ37257069-4EE31268-51FD-4EDF-B820-AEFFCCC9BD23
P2860
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Alpha-fetoprotein: reevaluation in hepatology.
@ast
Alpha-fetoprotein: reevaluation in hepatology.
@en
type
label
Alpha-fetoprotein: reevaluation in hepatology.
@ast
Alpha-fetoprotein: reevaluation in hepatology.
@en
prefLabel
Alpha-fetoprotein: reevaluation in hepatology.
@ast
Alpha-fetoprotein: reevaluation in hepatology.
@en
P2860
P356
P1433
P1476
Alpha-fetoprotein: reevaluation in hepatology.
@en
P2093
P2860
P304
P356
10.1002/HEP.1840120625
P407
P577
1990-12-01T00:00:00Z